If you would like to receive an invite, please contact Kurt Stratton-Lindsay at kurt@redproject.org OR by phone at 616-456-9063.
May 14th – 12pm
- This event has passed.
Speaking R.E.D. Luncheon
May 14, 2020 @ 12:00 pm - 1:00 pm
Follow us on Twitter
Finally, OTC naloxone!
Grateful to all the harm reduction advocates who continued to champion this
Next step: Make sure it is accessible to those who need it most at low/no cost for true naloxone liberation https://twitter.com/Filtermag_org/status/1641058872667283456
BREAKING: The FDA has approved the first naloxone product available without a prescription. While this removes the final regulatory barrier to naloxone access, it does not on its own lower the cost.
By @kastaliamedrano:
https://filtermag.org/fda-otc-naloxone-prescription/?utm_source=twitter&utm_medium=social&utm_campaign=filter
BREAKING: The FDA has approved the first naloxone product available without a prescription. While this removes the final regulatory barrier to naloxone access, it does not on its own lower the cost.
By @kastaliamedrano:
https://filtermag.org/fda-otc-naloxone-prescription/?utm_source=twitter&utm_medium=social&utm_campaign=filter
Calling xylazine “naloxone resistant” is a bit silly, considering that it’s not an opioid and therefore not meant for it. Xylazine is almost exclusively found WITH opioids, and so if someone isn’t adequately breathing, should still be given naloxone along w other supportive care